Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 2,844 | 2,016 | 757 | 859 | 637 |
| Cost of Goods | 468 | 484 | 320 | 431 | 322 |
| Gross Profit | 2,376 | 1,533 | 437 | 428 | 315 |
| Operating Expenses | 3,308 | 3,404 | 2,752 | 3,427 | 2,963 |
| Operating Income | -464 | -1,388 | -1,995 | -2,568 | -2,326 |
| Interest Expense | 81 | 1 | 0 | 0 | 2 |
| Other Income | 115 | -25 | 70 | 111 | 23 |
| Pre-tax Income | -430 | -1,414 | -1,925 | -2,457 | -2,305 |
| Net Income Continuous | -430 | -1,414 | -1,925 | -2,457 | -2,305 |
| Net Income | $-430 | $-1,414 | $-1,925 | $-2,457 | $-2,305 |
| EPS Basic Total Ops | -0.01 | -0.02 | -0.04 | -0.05 | -0.05 |
| EPS Basic Continuous Ops | -0.01 | -0.03 | -0.04 | -0.05 | -0.05 |
| EPS Diluted Total Ops | -0.01 | -0.02 | -0.04 | -0.05 | -0.05 |
| EPS Diluted Continuous Ops | -0.01 | -0.03 | -0.04 | -0.05 | -0.05 |
| EBITDA(a) | $-330 | $-1,271 | $-1,860 | $-2,444 | $-2,208 |